Jason Krentz

Jason Krentz is the Chief Operating Officer at Asklepios BioPharmaceutical, Inc. since August 2022, following a role as Chief Technology Officer at Tmunity Therapeutics Incorporated from April 2018 to August 2022. Prior experience includes serving as Vice President of Manufacturing Operations at Endo Pharmaceuticals (2015 - March 2018) and Vice President of Technical Operations at Auxilium Pharmaceuticals (2011 - 2015). Jason Krentz also held the position of Executive Director of Technical Operations at Tengion (2007 - 2011) and Associate Director of Cell Culture Operations at Centocor (2002 - 2007). Earlier in the career, Jason Krentz worked as a Product Engineer at Lucent Technologies / Agere Systems (2000 - 2002) and served as a Naval Officer in the US Navy from 1994 to 2000. Educational qualifications include a BS in Materials Science Engineering from the University of Michigan (1990 - 1994) and an MBA from Saint Joseph's University - Erivan K. Haub School of Business (2003 - 2007).